Showing results (1251-1260 of 1,275) with videos related to
Sort By:
Pageof 128
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.Breast Cancer Research : BCR|January 4, 2011
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control studyRoger L Milne, Mia M Gaudet, Amanda B Spurdle, et al.Journal of Medical Genetics|September 21, 2011
7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association ConsortiumRoger L Milne, Justo Lorenzo-Bermejo, Barbara Burwinkel, et al.International Journal of Cancer|September 18, 2014
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsAnja Rudolph, Roger L Milne, Thérèse Truong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.Plos Genetics|April 26, 2008
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristicsMontserrat Garcia-Closas, Per Hall, Heli Nevanlinna, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)Aline Talhouk, Joshy George, Chen Wang, et al.Pageof 128